文献速递膀胱癌与上尿路尿路上皮癌

开放根治性膀胱切除术后五联达标标准的肿瘤学验证与区分能力

Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy.
PubMed 文献 · BJU Int · 2022-09-28

本研究在2009年1月至2017年12月间420例接受开放根治性膀胱切除加盆腔淋巴结清扫和尿流改道的非转移性膀胱癌患者中,验证PROMETRICS组提出的五联达标标准(PC),并评估其区分肿瘤学终点的能力。中位随访73个月,108例(26%)达到全部PC;达到PC数量减少(<4/5)与总死亡率和癌症特异性死亡率的不良生存估计相关,但与其它原因死亡率无关。作者认为PC是非转移性膀胱癌开放根治性膀胱切除术后肿瘤学结局报告的准确质量指标,对长期总死亡率和癌症特异性死亡率有区分能力。

要点

  • 420例开放根治性膀胱切除患者中,108例(26%)达到全部五联达标标准。
  • 年龄校正Charlson合并症指数升高(OR 0.80,P=0.015)和不可控尿流改道(OR 0.38,P=0.005)是未达标的独立预测因素。
  • 达到PC数量减少(<4/5)与总死亡率和癌症特异性死亡率的不良生存估计相关,但与其它原因死亡率无关。

核心结论

  • PROMETRICS组提出的PC是非转移性膀胱癌开放根治性膀胱切除术后肿瘤学结局报告的准确质量指标,对长期总死亡率和癌症特异性死亡率有明确的区分能力。

研究设计与样本

  • 2009年1月至2017年12月间,420例非转移性膀胱癌患者接受开放根治性膀胱切除加盆腔淋巴结清扫和尿流改道。
  • PC按PROMETRICS组所述定义,主要终点为PC达标,肿瘤学结局为其他终点。
  • 采用单因素和多因素logistic回归分析评估PC达标的预测因素,采用Kaplan-Meier曲线和累积发生率函数比较PC对总死亡率、癌症特异性死亡率和其它原因死亡率的区分能力,并按达到PC数量分层后采用多因素Cox回归和竞争风险模型检验PC达标与生存终点的关联。

主要发现

  • 108例(26%)达到全部PC,分别有195例(46%)、77例(18%)、35例(8.3%)和5例(1.2%)达到4/5、3/5、2/5和≤1/5 PC。
  • 年龄校正Charlson合并症指数升高(OR 0.80,P=0.015)和不可控尿流改道(OR 0.38,P=0.005)是PC未达标的独立预测因素。
  • 中位随访73个月,PC达标(≥4/5 vs 3/5 vs ≤2/5 PC attained)用于将患者分层为死亡风险显著不同的组(P<0.001)。
  • 达到PC数量减少(<4/5)与总死亡率和癌症特异性死亡率的不良生存估计相关(所有P≤0.005),但与其它原因死亡率无关(所有P≥0.2)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To validate the pentafecta criteria (PC) proposed by the PROMETRICS group for outcome reporting after radical cystectomy in an open radical cystectomy (ORC) cohort with long-term follow-up and to assess the discriminative ability of PC attainment for oncological endpoints. PATIENTS AND METHODS: Between January 2009 and December 2017, 420 patients underwent ORC with pelvic lymph node dissection and urinary diversion for non-metastatic bladder cancer. The PC were defined as reported by the PROMETRICS group. The primary endpoint was PC attainment, and oncological outcomes comprised further endpoints. We used uni- and multivariable logistic regression analysis to assess predictors of PC attainment. The discriminative ability of PC for overall mortality (OM), cancer-specific mortality (CSM) and other-cause mortality (OCM) was compared using Kaplan-Meier curves and cumulative incidence functions. After stratification by the number of PC attained, the association between PC attainment and the survival endpoints was tested on multivariable Cox regression and competing-risks models. RESULTS: A total of 108 patients (26%) fulfilled all PC, while 195 (46%), 77 (18%), 35 (8.3%) and five (1.2%) attained 4/5, 3/5, 2/5 and ≤1/5 PC, respectively. Increasing age-adjusted Charlson comorbidity index (odds ratio [OR] 0.80, P = 0.015) and incontinent diversion (OR 0.38, P = 0.005) were independent predictors of PC non-attainment. The median follow-up was 73 months. PC attainment (≥4/5 vs 3/5 vs ≤2/5 PC attained) was used to stratify patients into groups at significantly different risk of death (P < 0.001). A decreasing number of PC attained (<4/5) was associated with unfavourable survival estimates for both OM and CSM (all P ≤ 0.005) but not for OCM (all P ≥ 0.2). CONCLUSIONS: The PC proposed by the PROMETRICS group represent accurate quality indicators for oncological outcome reporting after ORC for non-metastatic bladder cancer and have a distinct discriminative ability to predict long-term OM and CSM.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. von Deimling M, Rink M, Klemm J, et al. Oncological validation and discriminative ability of pentafecta criteria after open radical cystectomy. BJU Int. 2022. PMID: 36088640. doi:10.1111/bju.15890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。